Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
885
datasets available to search
ShareScore release 0.9.0
Dataset results
885 results for “cyclophosphamide”
Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00941720. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients
ClinicalTrials.gov study NCT00038142. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers
ClinicalTrials.gov study NCT01135329. IPD Sharing: NO. Countries: 1. Publications: 0.
Docetaxel, Doxorubicin and Cyclophosphamide Versus Vinorelbine and Capecitabine in Patients Not Sufficiently / Sufficiently Responding as Preoperative Treatment of Locally Advanced or Operable Primary
ClinicalTrials.gov study NCT00544765. IPD Sharing: Not stated. Countries: 0. Publications: 10.
Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/Lymphoma
ClinicalTrials.gov study NCT00669877. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Goserelin for Ovarian Protection in Premenopausal Patients Receiving Cyclophosphamide
ClinicalTrials.gov study NCT03475758. IPD Sharing: NO. Countries: 0. Publications: 1.
Cyclophosphamide, VELCADE, DOXIL, and Dexamethasone, (CVDD) in Newly Diagnosed Patients With Multiple Myeloma (MM)
ClinicalTrials.gov study NCT00750815. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
ClinicalTrials.gov study NCT00555048. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer
ClinicalTrials.gov study NCT01750073. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma
ClinicalTrials.gov study NCT01614197. IPD Sharing: NO. Countries: 3. Publications: 0.
Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Stage I-II Breast Cancer Who Have Undergone Surgery
ClinicalTrials.gov study NCT01106898. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Light Chain Amyloidosis
ClinicalTrials.gov study NCT01072773. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bortezomib, Liposomal Doxorubicin Hydrochloride, Dexamethasone, and Cyclophosphamide in Treating Patients With Multiple Myeloma That Relapsed After Autologous Stem Cell Transplant
ClinicalTrials.gov study NCT01078441. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01082939. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Therapy for Locally Advanced Breast Cancer Using Doxil, Paclitaxel, and Cyclophosphamide With Avastin
ClinicalTrials.gov study NCT00635050. IPD Sharing: NO. Countries: 1. Publications: 0.
Repeat Doses of SB-728mR-T After Cyclophosphamide Conditioning in HIV-Infected Subjects on HAART
ClinicalTrials.gov study NCT02225665. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Arsenic Trioxide With Cyclophosphamide in Patients With Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03318016. IPD Sharing: NO. Countries: 1. Publications: 0.
Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer
ClinicalTrials.gov study NCT00577122. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive I
ClinicalTrials.gov study NCT00464646. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides
ClinicalTrials.gov study NCT00430105. IPD Sharing: Not stated. Countries: 0. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.